Baxter's Robert Parkinson - CEO Pay
Baxter - Robert Parkinson
Total Compensation: $17.6M
2007 Revenue: $11.3B
2006 Revenue: $10.4B
Change: 8.6%
Details: Parkinson's $17.6 million haul was driven primarily by strong company and individual performance in 2007 and 2006. According to the company's proxy statement, Parkinson's compensation "reflects the role he has played in the turnaround of the company since his arrival in 2004." Parkinson gained $1.29M in base salary, $3.75M in stock option awards, and $2.28 in additional pension.
Baxter News:
Baxter: Fake heparin predated API
Baxter recalls heparin on adverse events
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: